Pulse Biosciences, Inc. Marketing and Advertising Expense
Pulse Biosciences, Inc. (PLSE) reported Marketing and Advertising Expense of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:MarketingAndAdvertisingExpense · last filed 2024-03-28
- Pulse Biosciences, Inc. marketing and advertising expense for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. marketing and advertising expense for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. marketing and advertising expense for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. marketing and advertising expense for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. marketing and advertising expense for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Pulse Biosciences, Inc. marketing and advertising expense for fiscal 2022 was $12.02M, a 18.52% decline from fiscal 2021.
- Pulse Biosciences, Inc. marketing and advertising expense for fiscal 2021 was $14.75M, a 103.29% increase from fiscal 2020.
- Pulse Biosciences, Inc. marketing and advertising expense for fiscal 2020 was $7.26M, a 23.89% increase from fiscal 2019.
| Period end | Marketing and Advertising Expense 3 month | Marketing and Advertising Expense 6 month | Marketing and Advertising Expense 9 month | Marketing and Advertising Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $768.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $768.00K derived: sum of 3 quarters · filed 2024-03-28 | $2.79M derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $768.00K derived: sum of 2 quarters · filed 2024-03-28 | $2.79M derived: sum of 3 quarters · filed 2024-03-28 | $6.48M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | $768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.79M derived: sum of 2 quarters · filed 2024-03-28 | $6.48M derived: sum of 3 quarters · filed 2024-03-28 | $12.02M 10-K · filed 2024-03-28 |
| 2022-09-30 | $2.02M 10-Q · filed 2023-11-13 | $5.71M derived: sum of 2 quarters · filed 2023-11-13 | $11.25M 10-Q · filed 2023-11-13 | $15.30M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $3.69M 10-Q · filed 2023-08-10 | $9.23M 10-Q · filed 2023-08-10 | $13.29M derived: sum of 3 quarters · filed 2023-08-10 | $16.69M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $5.54M 10-Q · filed 2023-05-11 | $9.60M derived: sum of 2 quarters · filed 2023-05-11 | $13.00M derived: sum of 3 quarters · filed 2023-05-11 | $16.15M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $7.46M derived: sum of 2 quarters · filed 2023-03-31 | $10.61M derived: sum of 3 quarters · filed 2023-03-31 | $14.75M 10-K · filed 2023-03-31 |
| 2021-09-30 | $3.40M 10-Q · filed 2022-11-10 | $6.55M derived: sum of 2 quarters · filed 2022-11-10 | $10.70M 10-Q · filed 2022-11-10 | $13.03M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | $3.15M 10-Q · filed 2022-08-10 | $7.29M 10-Q · filed 2022-08-10 | $9.62M derived: sum of 3 quarters · filed 2023-03-31 | $11.37M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-03-31 | $4.15M 10-Q · filed 2022-05-11 | $6.48M derived: sum of 2 quarters · filed 2023-03-31 | $8.22M derived: sum of 3 quarters · filed 2023-03-31 | $9.71M derived: sum of 4 quarters · filed 2023-03-31 |
| 2020-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.08M derived: sum of 2 quarters · filed 2023-03-31 | $5.56M derived: sum of 3 quarters · filed 2023-03-31 | $7.26M 10-K · filed 2023-03-31 |
| 2020-09-30 | $1.75M 10-Q · filed 2021-11-15 | $3.23M derived: sum of 2 quarters · filed 2021-11-15 | $4.93M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $1.49M 10-Q · filed 2021-08-09 | $3.18M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $1.70M 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $5.86M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |